Pooled data from 2 phase 1 trials show that etentamig (ABBV-383; AbbVie Inc) has a manageable safety profile and low incidence of grades 3 and 4 infection in patients with relapsed/refractory multiple myeloma (RRMM). The findings, presented at the…
Category: 6. Business
-
Predictors of cGVHD Outcomes Remain Elusive in Pediatric Hematologic Malignancies
Acute graft-vs-host disease (GVHD) was the only identifiable risk factor for the development of chronic GVHD (cGVHD) in pediatric patients with hematologic malignancies who underwent allogeneic hematopoietic stem cell transplant (HSCT) from…
Continue Reading
-
Institutional Adoption NOT CENTRAL BANK PURCHASES Pushing
Institutional Adoption NOT CENTRAL BANK PURCHASES Pushing | The Jerusalem PostJerusalem Post/Business & Innovation/Precious MetalsDisastrous fiscal policies: historic deficit spending, mounting tariffs, regulatory missteps, and unsustainabledebt…
Continue Reading
-
Human umbilical cord mesenchymal stem cell-derived exosomes prevent and alleviate experimental pulmonary fibrosis by modulating the cytoskeleton of macrophages | Stem Cell Research & Therapy
Isolation and identification of hucMSC-Exos
The exosome-specific MSC medium (Yumeibo Biotechnology Co., Ltd., Shanghai, China) was utilized to culture third-generation hucMSCs (Han’s United Bio-Technology Co., Ltd., Beijing, China) until a…
Continue Reading
-
Poll: Vote on the Top Breast Cancer, Hematology Abstracts to Watch at ESMO 2025
The
2025 ESMO Congress in Berlin is just around the corner, and anticipation is high for the scientific sessions that will drive discussions and shape care across tumor types. Each year, late-breaking abstracts (LBAs) and evolving thematic…Continue Reading
-
T-DXd Improves Invasive DFS vs T-DM1 in HER2+ Early Breast Cancer Subgroup
Fam-trastuzumab deruxtecan-nxki (T-DXd; Enhertu) improved invasive disease-free survival (IDFS) compared with trastuzumab emtansine (T-DM1; Kadcyla) as treatment for patients with HER2-positive early breast cancer with residual invasive disease in…
Continue Reading
-
‘Difficult’ year for Dyson sees profits down nearly 50% | Dyson Ltd
Profits at Dyson nearly halved during a “difficult” year in which the home appliances business, founded by the billionaire Sir James Dyson, cut more than a quarter of its UK workforce.
Dyson, which has been based in Singapore since 2019 in a…
Continue Reading
-
Kirkland Represents L Catterton on Dentalcorp’s $3.3 Billion Sale to GTCR | News
Kirkland & Ellis represented L Catterton in the all-cash sale of Dentalcorp Holdings Ltd. to GTCR, valuing Dentalcorp at approximately C$2.2 billion in equity and C$3.3 billion in enterprise value. The…
Continue Reading
-
Stocks pause, but rate cuts, economic growth may provide support – invesco.com
- Stocks pause, but rate cuts, economic growth may provide support invesco.com
- Market DIP Coming: How to Prepare Your Portfolio The Motley Fool
- Why The Correction Is Starting Seeking Alpha
- Some short-term weakness in the S&P 500 may be due, says…
Continue Reading
-
Siemens expands partnership with AI firm for “simulation-driven” manufacturing – News
ENGINEERING giant Siemens is set to automate its process and plant engineering capabilities through an expanded partnership with AI specialist L&T…
Continue Reading